SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs.
A completely new approach to drug discovery and development.
FDA cleared IND for open-label, Phase 1b, 30-subject trial of SFA002 in Mild to Moderate Psoriasis
29 June 2020
Our Latest News
Fill this Form to Get More Information
610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States